Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors

The Clinical Relevance of Chromogranin A as a Biomarker for Gastroenteropancreatic Neuroendocrine Tumors

(2011) Ben Lawrence et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

(2011) James C. Yao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Abstracts Presented at the 3rd Annual Meeting of the North American NeuroEndocrine Tumor Society, October 29-30, 2010, Santa Fe, New Mexico

(2011)   PANCREAS

Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours

(2010) Eva Tiensuu Janson et al.   ACTA ONCOLOGICA

Plasma Chromogranin A Response to Octreotide Test: Prognostic Value for Clinical Outcome in Endocrine Digestive Tumors

(2010) Sara Massironi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Chromogranin A—Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease

(2010) Irvin M. Modlin et al.   ANNALS OF SURGICAL ONCOLOGY

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

(2010) N C Turner et al.   BRITISH JOURNAL OF CANCER

18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors

(2010) T. Binderup et al.   CLINICAL CANCER RESEARCH

Consensus recommendations for the diagnosis and management of well-differentiated gastroenterohepatic neuroendocrine tumours: a revised statement from a Canadian national expert group

(2010) W. Kocha et al.   Current Oncology

IL-2 −330 T/G SNP and serum values—potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs)

(2010) Maja Cigrovski Berković et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

68Ga-DOTATATE PET/CT for the Early Prediction of Response to Somatostatin Receptor-Mediated Radionuclide Therapy in Patients with Well-Differentiated Neuroendocrine Tumors

(2010) A. R. Haug et al.   JOURNAL OF NUCLEAR MEDICINE

Early CgA Response as Predictor of Outcome Following Everolimus Therapy Among Patients With Low- to Intermediate- Grade Neuroendocrine Carcinoma

(2010) Carmen B. Jacobs et al.   PANCREAS

NANETS Consensus Guidelines for the Diagnosis of Neuroendocrine Tumor

(2010) Aaron I. Vinik et al.   PANCREAS

A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia

(2010) Constantin S. Jianu et al.   TUMOR BIOLOGY

Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies

(2010) Rafael Molina et al.   TUMOR BIOLOGY

[177Lu-DOTA0-Tyr3]-Octreotate Treatment in Patients with Disseminated Gastroenteropancreatic Neuroendocrine Tumors: The Value of Measuring Absorbed Dose to the Kidney

(2010) Christina Swärd et al.   WORLD JOURNAL OF SURGERY

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

(2009) Maria P Brizzi et al.   BMC CANCER

Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease

(2009) A. Frilling et al.   BRITISH JOURNAL OF SURGERY

Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study

(2009) A Ahmed et al.   ENDOCRINE-RELATED CANCER

Daily Oral Everolimus Activity in Patients With Metastatic Pancreatic Neuroendocrine Tumors After Failure of Cytotoxic Chemotherapy: A Phase II Trial

(2009) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors

(2009) Staffan Welin et al.   NEUROENDOCRINOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers

(2009) Dermot O’Toole et al.   NEUROENDOCRINOLOGY

Small intestinal neuroendocrine tumors: Prognostic factors and survival

(2009) Deidi Strickland Bergestuen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors

(2008) Sirianong Namwongprom et al.   ANNALS OF NUCLEAR MEDICINE

Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer

(2008) Michele Malaguarnera et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases

(2008) Julie King et al.   CANCER

Neuroendocrine tumor epidemiology

(2008) Oyvind Hauso et al.   CANCER

Plasma Chromogranin A as Marker for Survival in Patients With Metastatic Endocrine Gastroenteropancreatic Tumors

(2008) R ARNOLD et al.   Clinical Gastroenterology and Hepatology

Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours

(2008) Simona Grozinsky-Glasberg et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Concordance between results of somatostatin receptor scintigraphy with 111In-DOTA-DPhe1-Tyr3-octreotide and chromogranin A assay in patients with neuroendocrine tumours

(2008) Margarida Rodrigues et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY

Gastroenteropancreatic neuroendocrine tumours

(2008) Irvin M Modlin et al.   LANCET ONCOLOGY

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification

(2008) Günter Klöppel et al.   NEUROENDOCRINOLOGY

Chromogranin A as an Alternative to 5-Hydroxyindoleacetic Acid in the Evaluation of Symptoms during Treatment of Patients with Neuroendocrine Tumors

(2008) Catharina M. Korse et al.   NEUROENDOCRINOLOGY

Chromogranin A Levels in Diagnosis, Treatment and Follow-Up of 42 Patients with Non-Functioning Pancreatic Endocrine Tumours

(2008) G.C. Nikou et al.   PANCREATOLOGY